• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经丝轻链蛋白在非原发性神经疾病中的多方面作用。

The multifaceted role of neurofilament light chain protein in non-primary neurological diseases.

机构信息

Department of Neurology, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany.

Department of Neurology, University of California San Francisco (UCSF), San Francisco, USA.

出版信息

Brain. 2023 Feb 13;146(2):421-437. doi: 10.1093/brain/awac328.

DOI:10.1093/brain/awac328
PMID:36083979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9494370/
Abstract

The advancing validation and exploitation of CSF and blood neurofilament light chain protein as a biomarker of neuroaxonal damage has deeply changed the current diagnostic and prognostic approach to neurological diseases. Further, recent studies have provided evidence of potential new applications of this biomarker also in non-primary neurological diseases. In the present review we summarize the state of the art, future perspectives, but also limitations, of neurofilament light chain protein as a CSF and blood biomarker in several medical fields, including intensive care medicine, surgery, internal medicine and psychiatry. In particular, neurofilament light chain protein is associated with the degree of neurological impairment and outcome in patients admitted to intensive care units or in the perioperative phase and it seems to be highly interconnected with cardiovascular risk factors. Beyond that, interesting diagnostic and prognostic insights have been provided by the investigation of neurofilament light chain protein in psychiatric disorders as well as in the current coronavirus disease-19 pandemic and in normal ageing. Altogether, current data outline a multifaceted applicability of CSF and blood neurofilament light chain protein ranging from the critical clinical setting to the development of precision medicine models suggesting a strict interplay between the nervous system pathophysiology and the health-illness continuum.

摘要

脑脊液和血液神经丝轻链蛋白作为神经轴索损伤的生物标志物,其验证和应用的不断推进,极大地改变了神经疾病当前的诊断和预后方法。此外,最近的研究为这一生物标志物在非原发性神经疾病中的潜在新应用提供了证据。在本综述中,我们总结了神经丝轻链蛋白作为脑脊液和血液生物标志物在包括重症监护医学、外科、内科和精神病学在内的几个医学领域的最新进展、未来展望,但也指出了其局限性。神经丝轻链蛋白与入住重症监护病房或围手术期患者的神经损伤程度和预后相关,并且似乎与心血管危险因素高度相关。除此之外,在精神疾病以及当前的 COVID-19 大流行和正常衰老中对神经丝轻链蛋白的研究提供了有趣的诊断和预后见解。总的来说,目前的数据描绘了脑脊液和血液神经丝轻链蛋白的多方面适用性,从关键的临床环境到精准医学模型的发展,提示神经系统病理生理学与健康-疾病连续体之间存在密切的相互作用。

相似文献

1
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases.神经丝轻链蛋白在非原发性神经疾病中的多方面作用。
Brain. 2023 Feb 13;146(2):421-437. doi: 10.1093/brain/awac328.
2
Neurofilament light chain as a biomarker in neurological disorders.神经丝轻链作为神经紊乱的生物标志物。
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9.
3
Serum neurofilament light chain studies in neurological disorders, hints for interpretation.神经系统疾病中的血清神经丝轻链研究:解读要点
J Neurol Sci. 2020 Sep 15;416:116986. doi: 10.1016/j.jns.2020.116986. Epub 2020 Jun 14.
4
Neurofilaments as biomarkers in neurological disorders - towards clinical application.神经丝作为神经紊乱的生物标志物——迈向临床应用。
Nat Rev Neurol. 2024 May;20(5):269-287. doi: 10.1038/s41582-024-00955-x. Epub 2024 Apr 12.
5
Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels.神经丝在神经系统疾病患者中的水平:神经丝轻链和重链水平的比较。
J Clin Lab Anal. 2019 Sep;33(7):e22948. doi: 10.1002/jcla.22948. Epub 2019 Jun 14.
6
Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease.神经丝轻链作为脑小血管病的生物标志物
Mol Diagn Ther. 2022 Jan;26(1):1-6. doi: 10.1007/s40291-021-00566-y. Epub 2021 Nov 25.
7
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.新冠病毒感染患者无主要神经表现时的血清神经丝轻链水平。
J Neurol. 2022 Nov;269(11):5691-5701. doi: 10.1007/s00415-022-11233-5. Epub 2022 Jul 4.
8
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.CSF 或血清神经丝轻链添加到 α-突触核蛋白检测面板可区分帕金森病与对照组。
Mov Disord. 2020 Feb;35(2):288-295. doi: 10.1002/mds.27897. Epub 2019 Nov 18.
9
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?一项关于脑脊液神经丝轻链在区分神经退行性疾病与精神障碍中的效用的初步研究:精神科医生和神经科医生的“C 反应蛋白”?
Aust N Z J Psychiatry. 2020 Jan;54(1):57-67. doi: 10.1177/0004867419857811. Epub 2019 Jun 21.
10
Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.磷酸化神经丝重链:肌萎缩侧索硬化症的一种潜在诊断生物标志物。
J Neurophysiol. 2022 Mar 1;127(3):737-745. doi: 10.1152/jn.00398.2021. Epub 2022 Feb 9.

引用本文的文献

1
Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank.阿尔茨海默病血浆生物标志物轨迹、脑结构与认知功能之间的关联:英国生物银行的一项前瞻性队列研究
Mol Psychiatry. 2025 Aug 28. doi: 10.1038/s41380-025-03166-y.
2
Association between polyunsaturated fatty acids intake and serum neurofilament light chain concentrations in American adults: a cross-sectional study.美国成年人多不饱和脂肪酸摄入量与血清神经丝轻链浓度之间的关联:一项横断面研究。
Front Nutr. 2025 Jul 11;12:1608211. doi: 10.3389/fnut.2025.1608211. eCollection 2025.
3
Associations of serum neurofilament and asthma: evidence from the NHANES 2013-2014.血清神经丝与哮喘的关联:来自2013 - 2014年美国国家健康与营养检查调查(NHANES)的证据。
Front Neurol. 2025 Jul 4;16:1567158. doi: 10.3389/fneur.2025.1567158. eCollection 2025.
4
Insight into NeuroCOVID: neurofilament light chain (NfL) as a biomarker in post-COVID-19 patients with olfactory dysfunctions.深入了解神经新冠:神经丝轻链(NfL)作为新冠后嗅觉功能障碍患者的生物标志物
J Neurol. 2025 Jul 1;272(7):484. doi: 10.1007/s00415-025-13222-w.
5
A study on structural imaging changes and serum neurofilament light chain (NfL) levels in individuals with white matter hyperintensities, combining imaging techniques with biomarker analysis.一项关于白质高信号个体的结构成像变化和血清神经丝轻链(NfL)水平的研究,将成像技术与生物标志物分析相结合。
IBRO Neurosci Rep. 2025 May 21;18:794-802. doi: 10.1016/j.ibneur.2025.05.008. eCollection 2025 Jun.
6
Evidence that minocycline treatment confounds the interpretation of neurofilament as a biomarker.米诺环素治疗会混淆将神经丝作为生物标志物的解读的证据。
Brain Commun. 2025 May 23;7(3):fcaf175. doi: 10.1093/braincomms/fcaf175. eCollection 2025.
7
Lipocalin 2 Facilitates the Initial Compromise of the Blood-Brain Barrier Integrity in Chronic Cerebral Hypoperfusion.脂质运载蛋白2促进慢性脑灌注不足时血脑屏障完整性的初始破坏。
CNS Neurosci Ther. 2025 May;31(5):e70438. doi: 10.1111/cns.70438.
8
Plasma Glial Fibrillary Acidic Protein and Neurofilament Light Are Elevated in Bipolar Depression: Evidence for Neuroprogression and Astrogliosis.双相抑郁患者血浆中胶质纤维酸性蛋白和神经丝轻链水平升高:神经进展和星形胶质细胞增生的证据
Bipolar Disord. 2025 Apr 23. doi: 10.1111/bdi.70029.
9
Association of serum neurofilament light chain and bone mineral density in adults.成人血清神经丝轻链与骨密度的关联
BMC Musculoskelet Disord. 2025 Apr 21;26(1):391. doi: 10.1186/s12891-025-08639-3.
10
Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis.帕金森病和非典型帕金森综合征中的脑脊液和血液神经丝轻链:系统评价和贝叶斯网络荟萃分析
J Neurol. 2025 Apr 3;272(4):311. doi: 10.1007/s00415-025-13051-x.